 |
 Play Video: The Importance of Insider Buying
|
|
|
| Date | Insider | Price | Amount |
|---|
12-2-2022
Insider Buy |
Carl Daikeler
SEE REMARKS |
$0.70
CAGR »
|
$80,482.51
114,811 shares |
12-2-2022
Insider Buy |
Jonathan Congdon
CO-FOUNDER AND VICE CHAIRMAN |
$0.70
CAGR »
|
$175,945.00
250,000 shares |
12-1-2022
Insider Buy |
Carl Daikeler
SEE REMARKS |
$0.70
CAGR »
|
$155,000.20
220,456 shares |
11-30-2022
Insider Buy |
Marc Suidan
CHIEF FINANCIAL OFFICER |
$0.70
CAGR »
|
$35,000.00
50,000 shares |
11-30-2022
Insider Buy |
Kathy P. Vrabeck
CHIEF OPERATING OFFICER |
$0.70
CAGR »
|
$175,250.00
250,000 shares |
6-1-2022
Insider Buy |
Carl Daikeler
SEE REMARKS |
$2.20
CAGR »
|
$1,297,451.50
588,800 shares |
5-27-2022
Insider Buy |
Carl Daikeler
SEE REMARKS |
$1.92
CAGR »
|
$1,859,208.70
970,226 shares |
5-24-2022
Insider Buy |
Carl Daikeler
SEE REMARKS |
$1.55
CAGR »
|
$1,270,691.33
818,974 shares |
5-20-2022
Insider Buy |
Michael Heller
Director |
$1.32
CAGR »
|
$297,092.79
224,423 shares |
5-19-2022
Insider Buy |
Jonathan Congdon
CO-FOUNDER AND VICE CHAIRMAN |
$1.22
CAGR »
|
$244,590.00
200,000 shares |
5-19-2022
Insider Buy |
Carl Daikeler
See Remarks |
$1.18
CAGR »
|
$575,937.59
486,675 shares |
5-17-2022
Insider Buy |
Marc Suidan
CHIEF FINANCIAL OFFICER |
$1.10
CAGR »
|
$25,265.50
23,000 shares |
5-18-2022
Insider Buy |
Kathy P. Vrabeck
CHIEF OPERATING OFFICER |
$1.07
CAGR »
|
$499,986.61
468,418 shares |
3-7-2013
Insider Buy |
Donna R. Ecton
Director |
$7.75
CAGR »
|
$7,750.00
1,000 shares |
9-24-2012
Insider Buy |
David A. Katz
Director |
$11.24
CAGR »
|
$11,242.00
1,000 shares |
8-29-2012
Insider Buy |
Donna R. Ecton
Director |
$8.90
CAGR »
|
$8,900.00
1,000 shares |
8-27-2012
Insider Buy |
Thomas W. Stoltz
COO and CFO |
$8.73
CAGR »
|
$87,300.00
10,000 shares |
8-24-2012
Insider Buy |
Robert Glass
Director |
$8.55
CAGR »
|
$50,012.24
5,850 shares |
8-21-2012
Insider Buy |
John K. Haley
Director |
$8.55
CAGR »
|
$29,918.00
3,500 shares |
8-21-2012
Insider Buy |
Matthew Swartwood
Senior Vice President, Sales |
$8.40
CAGR »
|
$2,520.00
300 shares |
5-8-2012
Insider Buy |
Matthew Swartwood
Senior Vice President, Sales |
$14.64
CAGR »
|
$19,915.57
1,360 shares |
5-8-2012
Insider Buy |
Donna R. Ecton
Director |
$14.50
CAGR »
|
$14,500.00
1,000 shares |
Also See: Institutional Holders of BODY
Also See: SEC filings
Below we present the annualized performance delivered by BODY stock since 12-2-2022 (the date of the most recent
insider purchase). The performance of the investment from the time BODY insider buying occurred is the ultimate
test of whether insiders were right about BODY being a good buy.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
12/05/2022 |
|
| End date: |
03/01/2024 |
|
| Start price/share: |
$35.55 |
|
| End price/share: |
$8.14 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-77.10% |
|
| Average Annual Total Return: |
-69.59% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$2,289.76 |
|
| Years: |
1.24 |
|
BODY Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.),
and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these
categories, but instead file their holdings quarterly on the latest form 13F filings.
While recent BODY insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding BODY
|
|
Free BODY Email Alerts:
